Skip to main content

Advertisement

Log in

Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

An Erratum to this article was published on 25 October 2009

Abstract

Polyphenols, the most abundant dietary antioxidants, also possess many other anticarcinogenic activities. Urinary metabolites of polyphenols could complement dietary assessment of the bioavailability of these nutrients. We conducted a study of 353 incident breast cancer cases and 701 individually matched controls nested within the Shanghai Women’s Health Study cohort of women aged 40–70 years at baseline. Liquid chromatography photo-diode array electrospray mass spectrometry was used to measure tea polyphenols (epicatechin, epigallocatechin, and their metabolites) and flavonols (e.g., quercetin and kaempferol). Multivariate conditional logistic regression analyses were used to assess associations between breast cancer risk and urinary excretion rates of polyphenols. Urinary excretion of tea polyphenols increased with increasing tea leaves consumed among controls, but not among breast cancer cases. Compared with cases, controls had higher levels of urinary total polyphenols and tea polyphenols, particularly epicatechin. In contrast, we did not find any dose–response relationship between urinary polyphenols and breast cancer risk. Urinary excretion of epicatechin was inversely associated with breast cancer risk [odds ratio (OR) and 95% confidence interval (CI) of 0.59 (0.39–0.88) for the intermediate tertile]. In spline regression, we found an overall dose–response relationship between epicatechin level and risk of breast cancer, although it was not apparent in low and middle urinary excretion range. In conclusion, high epicatechin may be related to a reduced risk of breast cancer. Further studies are warranted to confirm our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85:1819–1827

    Article  CAS  PubMed  Google Scholar 

  2. Adlercreutz H, Mazur W (1997) Phyto-oestrogens and western diseases. Ann Med 29:95–120

    CAS  PubMed  Google Scholar 

  3. Dai Q, Franke AA, Jin F, Shu XO, Hebert JR, Custer LJ, Cheng J, Gao YT, Zheng W (2002) Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 11:815–821

    CAS  PubMed  Google Scholar 

  4. Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W (2003) Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol Biomarkers Prev 12:497–502

    CAS  PubMed  Google Scholar 

  5. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W (2001) Population-based case–control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85:372–378

    Article  CAS  PubMed  Google Scholar 

  6. Zheng W, Dai Q, Custer LJ, Shu XO, Wen WQ, Jin F, Franke AA (1999) Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 8:35–40

    CAS  PubMed  Google Scholar 

  7. Willett WC (2001) Diet and breast cancer. J Intern Med 249:395–411

    Article  CAS  PubMed  Google Scholar 

  8. Wu AH, Ursin G, Koh WP, Wang R, Yuan JM, Khoo KS, Yu MC (2008) Green tea, soy, and mammographic density in Singapore Chinese women. Cancer Epidemiol Biomarkers Prev 17:3358–3365

    Article  CAS  PubMed  Google Scholar 

  9. Key TJ, Sharp GB, Appleby PN, Beral V, Goodman MT, Soda M, Mabuchi K (1999) Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 81:1248–1256

    Article  CAS  PubMed  Google Scholar 

  10. Satoh K, Sakamoto Y, Ogata A, Nagai F, Mikuriya H, Numazawa M, Yamada K, Aoki N (2002) Inhibition of aromatase activity by green tea extract catechins and their endocrinological effects of oral administration in rats. Food Chem Toxicol 40:925–933

    Article  CAS  PubMed  Google Scholar 

  11. Monteiro R, Becker H, Azevedo I, Calhau C (2006) Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. J Agric Food Chem 54:2938–2943

    Article  CAS  PubMed  Google Scholar 

  12. Monteiro R, Faria A, Mateus N, Calhau C, Azevedo I (2008) Red wine interferes with oestrogen signalling in rat hippocampus. J Steroid Biochem Mol Biol 111:74–79

    Article  CAS  PubMed  Google Scholar 

  13. Hatono S, Jimenez A, Wargovich MJ (1996) Chemopreventive effect of S-allylcysteine and its relationship to the detoxification enzyme glutathione S-transferase. Carcinogenesis 17:1041–1044

    Article  CAS  PubMed  Google Scholar 

  14. Le Marchand L (2002) Cancer preventive effects of flavonoids-a review. Biomed Pharmacother 56:296–301

    Article  CAS  PubMed  Google Scholar 

  15. Muto S, Fujita K, Yamazaki Y, Kamataki T (2001) Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 479:197–206

    CAS  PubMed  Google Scholar 

  16. Singh A, Singh SP (1997) Modulatory potential of smokeless tobacco on the garlic, mace or black mustard-altered hepatic detoxication system enzymes, sulfhydryl content and lipid peroxidation in murine system. Cancer Lett 118:109–114

    Article  CAS  PubMed  Google Scholar 

  17. Steele VE, Kelloff GJ, Balentine D, Boone CW, Mehta R, Bagheri D, Sigman CC, Zhu S, Sharma S (2000) Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis 21:63–67

    Article  CAS  PubMed  Google Scholar 

  18. Weisburger JH, Nagao M, Wakabayashi K, Oguri A (1994) Prevention of heterocyclic amine formation by tea and tea polyphenols. Cancer Lett 83:143–147

    Article  CAS  PubMed  Google Scholar 

  19. Ju YH, Doerge DR, Woodling KA, Hartman JA, Kwak J, Helferich WG (2008) Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 29:2162–2168

    Article  CAS  PubMed  Google Scholar 

  20. Beltz LA, Bayer DK, Moss AL, Simet IM (2006) Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 6:389–406

    Article  CAS  PubMed  Google Scholar 

  21. Berletch JB, Liu C, Love WK, Andrews LG, Katiyar SK, Tollefsbol TO (2008) Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG. J Cell Biochem 103:509–519

    Article  CAS  PubMed  Google Scholar 

  22. Yang CS, Sang S, Lambert JD, Hou Z, Ju J, Lu G (2006) Possible mechanisms of the cancer-preventive activities of green tea. Mol Nutr Food Res 50:170–175

    Article  CAS  PubMed  Google Scholar 

  23. Yokoyama M, Noguchi M, Nakao Y, Ysunaga M, Yamasaki F, Iwasaka T (2008) Antiproliferative effects of the major tea polyphenol, (−)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma. Gynecol Oncol 108:326–331

    Article  CAS  PubMed  Google Scholar 

  24. Collins-Burow BM, Burow ME, Duong BN, McLachlan JA (2000) Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms. Nutr Cancer 38:229–244

    Article  CAS  PubMed  Google Scholar 

  25. Bazemore R, Rouseff R, Naim M (2003) Linalool in orange juice: origin and thermal stability. J Agric Food Chem 51:196–199

    Article  CAS  PubMed  Google Scholar 

  26. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727–747

    CAS  PubMed  Google Scholar 

  27. Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S–2085S

    CAS  PubMed  Google Scholar 

  28. Franke AA, Custer LJ (1994) High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J Chromatogr B Biomed Appl 662:47–60

    Article  CAS  PubMed  Google Scholar 

  29. Fuhr U, Kummert AL (1995) The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther 58:365–373

    Article  CAS  PubMed  Google Scholar 

  30. Rowland IR, Wiseman H, Sanders TA, Adlercreutz H, Bowey EA (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36:27–32

    Article  CAS  PubMed  Google Scholar 

  31. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, Adlercreutz H (2001) Determinants of serum enterolactone concentration. Am J Clin Nutr 73:1094–1100

    CAS  PubMed  Google Scholar 

  32. Shapiro TA, Fahey JW, Wade KL, Stephenson KK, Talalay P (1998) Human metabolism and excretion of cancer chemoprotective glucosinolates and isothiocyanates of cruciferous vegetables. Cancer Epidemiol Biomarkers Prev 7:1091–1100

    CAS  PubMed  Google Scholar 

  33. Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F, Franke AA (1999) Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer 33:82–87

    Article  CAS  PubMed  Google Scholar 

  34. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, Li HL, Wen W, Ji BT, Li Q, Shu XO, Gao YT (2005) The Shanghai Women’s Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 162:1123–1131

    Article  PubMed  Google Scholar 

  35. Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA (2008) Urinary isoflavonoid excretion is similar after consuming soya milk and miso soup in Japanese-American women. Br J Nutr 100:424–429

    Article  CAS  PubMed  Google Scholar 

  36. Franke AA, Custer LJ, Wilkens LR, Le Marchand LL, Nomura AM, Goodman MT, Kolonel LN (2002) Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 777:45–59

    Article  CAS  PubMed  Google Scholar 

  37. Blair RM, Appt SE, Franke AA, Clarkson TB (2003) Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 133:2262–2267

    CAS  PubMed  Google Scholar 

  38. Maskarinec G, Hebshi S, Custer L, Franke AA (2008) The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eur J Cancer Prev 17:67–70

    Article  PubMed  Google Scholar 

  39. Franke AA, Custer LJ, Wang W, Shi CY (1998) HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 217:263–273

    CAS  PubMed  Google Scholar 

  40. (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163

  41. Dai Q, Gao YT, Shu XO, Yang G, Milne G, Cai Q, Wen W, Rothman N, Cai H, Li H, Xiang Y, Chow WH, Zheng W (2009) Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women’s Health Study. J Clin Oncol 27:2482–2488

    Article  PubMed  Google Scholar 

  42. Harrell FEJ (2001) Regression modeling strategies: with application to linear models, logistic regression and survival analysis. Springer, New York

    Google Scholar 

  43. Yuan JM, Gao YT, Yang CS, Yu MC (2007) Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai cohort study. Int J Cancer 120:1344–1350

    Article  CAS  PubMed  Google Scholar 

  44. Wu AH, Tseng CC, Van Den Berg D, Yu MC (2003) Tea intake, COMT genotype, and breast cancer in Asian–American women. Cancer Res 63:7526–7529

    CAS  PubMed  Google Scholar 

  45. Zhu BT, Conney AH (1998) Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 58:2269–2277

    CAS  PubMed  Google Scholar 

  46. Dias Pereira P, Lopes CC, Matos AJ, Pinto D, Gartner F, Lopes C, Medeiros R (2008) Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors. Vet Pathol 45:124–130

    Article  CAS  PubMed  Google Scholar 

  47. Hamaguchi M, Nishio M, Toyama T, Sugiura H, Kondo N, Fujii Y, Yamashita H (2008) Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. Jpn J Clin Oncol 38:734–742

    Article  PubMed  Google Scholar 

  48. Ji Y, Olson J, Zhang J, Hildebrandt M, Wang L, Ingle J, Fredericksen Z, Sellers T, Miller W, Dixon JM, Brauch H, Eichelbaum M, Justenhoven C, Hamann U, Ko Y, Bruning T, Chang-Claude J, Wang-Gohrke S, Schaid D, Weinshilboum R (2008) Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res 68:5997–6005

    Article  CAS  PubMed  Google Scholar 

  49. Thompson PA, Shields PG, Freudenheim JL, Stone A, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T, Kadlubar FF, Ambrosone CB (1998) Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res 58:2107–2110

    CAS  PubMed  Google Scholar 

  50. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, Negri E, Franceschi S, Montella M, Peterson J, Dwyer J, Giacosa A, La Vecchia C (2005) Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev 14:805–808

    Article  CAS  PubMed  Google Scholar 

  51. Peterson J, Lagiou P, Samoli E, Lagiou A, Katsouyanni K, La Vecchia C, Dwyer J, Trichopoulos D (2003) Flavonoid intake and breast cancer risk: a case–control study in Greece. Br J Cancer 89:1255–1259

    Article  CAS  PubMed  Google Scholar 

  52. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, Schroeder JC, Teitelbaum SL, Neugut AI, Gammon MD (2007) Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165:514–523

    Article  PubMed  Google Scholar 

  53. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD (2009) Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89(3):905–912

    Article  CAS  PubMed  Google Scholar 

  54. Sun CL, Yuan JM, Koh WP, Yu MC (2006) Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27:1310–1315

    Article  CAS  PubMed  Google Scholar 

  55. Seely D, Mills EJ, Wu P, Verma S, Guyatt GH (2005) The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther 4:144–155

    Article  PubMed  Google Scholar 

  56. Shrubsole MJ, Lu W, Chen Z, Shu XO, Zheng Y, Dai Q, Cai Q, Gu K, Ruan ZX, Gao YT, Zheng W (2009) Drinking green tea modestly reduces breast cancer risk. J Nutr 139:310–316

    CAS  PubMed  Google Scholar 

  57. Zhang M, Huang J, Xie X, Holman CD (2009) Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124:1404–1408

    Article  CAS  PubMed  Google Scholar 

  58. Dai Q, Shu XO, Li HGY, Martha J. Shrubsole, Hui Cai, Butian Ji, Wanqing Wen, Adrian Franke, Yu-Tang Gao, Wei Zheng (2009) Is green tea drinking associated with a later onset of breast cancer? Ann Epidemiol (submitted)

  59. Fleischauer AT, Arab L (2001) Garlic and cancer: a critical review of the epidemiologic literature. J Nutr 131:1032S–1040S

    CAS  PubMed  Google Scholar 

  60. Torres-Sanchez L, Lopez-Carrillo L, Lopez-Cervantes M, Rueda-Neria C, Wolff MS (2000) Food sources of phytoestrogens and breast cancer risk in Mexican women. Nutr Cancer 37:134–139

    Article  CAS  PubMed  Google Scholar 

  61. Kim JY, Kwon O (2009) Garlic intake and cancer risk: an analysis using the Food and Drug Administration’s evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr 89:257–264

    Article  CAS  PubMed  Google Scholar 

  62. Malin AS, Qi D, Shu XO, Gao YT, Friedmann JM, Jin F, Zheng W (2003) Intake of fruits, vegetables and selected micronutrients in relation to the risk of breast cancer. Int J Cancer 105:413–418

    Article  CAS  PubMed  Google Scholar 

  63. Yang CS, Sang S, Lambert JD, Lee MJ (2008) Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 52(Suppl 1):S139–S151

    PubMed  Google Scholar 

  64. Friedman M, Mackey BE, Kim HJ, Lee IS, Lee KR, Lee SU, Kozukue E, Kozukue N (2007) Structure-activity relationships of tea compounds against human cancer cells. J Agric Food Chem 55:243–253

    Article  CAS  PubMed  Google Scholar 

  65. Nagarajan S, Nagarajan R, Braunhut SJ, Bruno F, McIntosh D, Samuelson L, Kumar J (2008) Biocatalytically oligomerized epicatechin with potent and specific anti-proliferative activity for human breast cancer cells. Molecules 13:2704–2716

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the study participants. The authors also thank Laurie Custer for the skillful performance of LC/MS assays. We acknowledge the support by NIH grant S10 RR020890-01. Sources of support: This study was supported by USPHS grant R01CA106591 as well as USPHS grant R01CA70867 and NIH intramural program (N02 CP1101066) for the parent study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qi Dai.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s10549-009-0599-3

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luo, J., Gao, YT., Chow, WH. et al. Urinary polyphenols and breast cancer risk: results from the Shanghai Women’s Health Study. Breast Cancer Res Treat 120, 693–702 (2010). https://doi.org/10.1007/s10549-009-0487-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-009-0487-x

Keywords

Navigation